Now this is where a bitter political fight over transgender-related medical care for minors turns into something considerably more concrete: billing codes, insurance claims and potential federal fraud investigations.
Vice President J.D. Vance and Health and Human Services Secretary Robert F. Kennedy Jr. have referred hospitals and clinics identified in a new HHS report to the Justice Department and the HHS inspector general for possible violations of federal law.
And we’re not talking about a handful of facilities.
According to HHS, 225 hospitals established pediatric gender programs.
The administration’s report carries the less-than-subtle title “Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of ‘Gender Medicine.’” Vance called its allegations “deeply disturbing.”
“For years now, some hospitals and healthcare providers have been subjecting children to horrific, experimental treatments in service of radical gender ideologies,” Vance said.
Then he got to the financial allegation.
“More than just pushing these procedures on kids, hospitals and providers may have been defrauding Medicaid and private insurers by using misleading or fraudulent billing codes to get insurance to cover the costs,” he said.
That’s the key word here: may.
A referral isn’t a conviction. It isn’t even proof that criminal charges are coming. The administration is asking federal investigators to determine whether providers knowingly submitted false information to insurers.
And the specific allegation is worth following.
In a referral letter to Attorney General Todd Blanche, Vance said some pediatric gender clinics and children’s hospitals apparently used “misleading or even fraudulent diagnostic and billing codes” so insurers would pay for procedures.
One diagnosis appearing in the dispute is “endocrine disorder, unspecified.”
Vance cited research indicating that only 4.7 percent of patients given that diagnosis actually had the condition. He also pointed to a separate study showing a 30 percent increase in endocrine-disorder diagnoses, arguing that the increase raises questions about how the code was being used.
“This miscoding has allowed hospitals to bill insurance companies tens of millions of dollars for medications like puberty-blocking drugs,” Vance wrote.
And there is real money involved.
Politico reported that HHS examined claims in a nationwide database covering 2015 through 2025. According to that analysis, public and private insurers were billed nearly $50 million for puberty-blocking drugs provided to patients ages 9 through 17 who had an endocrine-disorder diagnosis.
Now, stay with me, because this is where investigators have work to do.
A suspicious pattern in a database does not automatically establish fraud. Medical billing is notoriously complicated, and an incorrect code can result from mistakes, coding practices or disputes over which diagnosis applies. Criminal fraud generally requires considerably more than pointing at a spreadsheet and saying, “That looks strange.”
Investigators would need to examine records, billing practices and what individual providers knew when claims were submitted.
Kennedy says that’s exactly what should happen.
“The findings raise serious questions about what families were told, what insurers were told, and how these procedures were billed,” he said.
“Doctors and hospitals must put children’s health ahead of ideology and financial gain,” Kennedy continued. “This report identifies troubling billing practices that demand scrutiny.”
Vance was even more emphatic.
“These allegations are crazy, and they demand investigation,” he said while announcing the referrals.